Altimmune, Inc. (ALT) income statement
ALTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.33−0.08 (-5.67%)
Close on Nov 20, 2026Market cap $258.71MP/E –Yield –
Altimmune, Inc. financial ratios
See a number that looks wrong?
Close on Nov 20, 2026Market cap $258.71MP/E –Yield –
See a number that looks wrong?
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Margins | |||||||||||||||||
| Operating margin | -230,461.0% | -515,860.0% | -22,518.5% | 129,029.4% | -2,197.6% | -669.5% | -370.0% | -414.6% | -484.7% | -342.7% | – | – | – | – | -48.3% | -112.2% | – |
| EBITDA margin | – | – | – | 129,330.9% | -2,185.1% | -664.3% | -363.3% | – | – | – | – | – | – | – | -46.4% | -107.3% | – |
| Pre-tax margin | -216,522.0% | -475,295.0% | -20,762.2% | 124,867.6% | -2,201.6% | -665.4% | -354.7% | -438.7% | -484.8% | -342.6% | – | – | – | – | -15.6% | -166.0% | – |
| Net profit margin | -214,861.0% | -475,295.0% | -20,762.2% | 124,577.9% | -2,201.6% | -599.2% | -353.7% | -379.2% | -432.3% | -342.6% | – | – | – | – | -15.6% | -166.0% | – |
| Free cash flow margin | -164,746.3% | – | -17,806.8% | 92,223.5% | -2,048.9% | -421.6% | -165.5% | -100.3% | -189.3% | -200.2% | – | – | – | – | -32.5% | -72.6% | – |
| Returns on capital | |||||||||||||||||
| Return on equity | -50.6% | -59.9% | -46.6% | -44.1% | -45.7% | -36.1% | -44.7% | -96.9% | -143.4% | -30.4% | -11.2% | -77.7% | -123.3% | -35.7% | -27.1% | -453.7% | – |
| Return on assets | -42.0% | -54.3% | -42.4% | -39.8% | -41.9% | -32.8% | -37.7% | -66.5% | -91.5% | -38.1% | -16.4% | -50.9% | -58.8% | -21.6% | -15.2% | -128.1% | – |
| Return on tangible assets | -42.0% | -54.3% | -42.4% | -42.3% | -44.2% | -35.9% | -49.2% | -87.0% | -387.1% | 242.0% | 218.5% | -57.8% | -66.6% | -24.1% | -16.8% | -140.2% | – |
| Return on invested capital | 522.8% | – | – | -911.2% | -696.0% | -396.1% | -130.8% | -214.0% | – | – | -13.8% | -29,992.3% | -703.7% | -179.6% | – | – | – |
| Return on capital employed | -48.0% | -63.0% | -49.4% | -44.9% | -44.7% | -38.7% | -42.8% | -78.3% | -113.0% | -43.8% | -18.4% | -68.5% | -84.7% | -37.5% | -59.8% | -112.0% | – |
| Return on total capital | -36.5% | – | – | -44.9% | -45.3% | -39.8% | -44.0% | -85.4% | – | – | -10.9% | -69.9% | -84.6% | -40.5% | – | – | – |
| NOPAT | -$74.65M | -$81.51M | -$75.78M | -$69.31M | -$76.56M | -$43.29M | -$16.96M | -$33.84M | -$41.12M | -$8.76M | -$2.69M | -$8.05M | -$8.56M | -$4.95M | -$9.26M | -$18.61M | – |
| Cash flow quality | |||||||||||||||||
| OCF / Sales | -164,719.5% | -399,240.0% | -17,795.8% | 92,038.2% | -1,774.1% | -419.1% | -165.5% | -90.9% | -188.2% | -196.3% | – | – | – | – | -32.2% | -70.8% | – |
| OCF / Net income | 0.77 | 0.84 | 0.86 | 0.74 | 0.81 | 0.70 | 0.47 | 0.24 | 0.44 | 0.57 | 0.93 | 0.85 | 0.61 | 0.47 | 2.06 | 0.43 | – |
| FCF / OCF | 100.0% | – | 100.1% | 100.2% | 115.5% | 100.6% | 100.0% | 110.4% | 100.6% | 102.0% | 102.7% | 101.1% | 101.2% | – | 100.9% | 102.5% | – |
| FCF / Net income | 0.77 | – | 0.86 | 0.74 | 0.93 | 0.70 | 0.47 | 0.26 | 0.44 | 0.58 | 0.96 | 0.86 | 0.62 | – | 2.08 | 0.44 | – |
| FCF / EBITDA | – | – | – | 71.3% | 93.8% | 63.5% | 45.6% | – | – | – | – | – | – | – | 70.0% | 67.6% | – |
| Unlevered free cash flow | -$66.25M | – | -$75.83M | -$62.71M | -$90.35M | -$34.50M | -$9.60M | -$10.13M | -$20.20M | -$6.45M | -$3.26M | -$8.40M | -$6.96M | – | -$7.84M | -$10.55M | – |
| Levered free cash flow | -$67.55M | – | -$75.86M | -$62.71M | -$90.36M | -$34.51M | -$9.60M | -$10.36M | -$20.33M | -$6.48M | -$3.30M | -$8.57M | -$7.25M | – | -$7.88M | -$15.24M | – |
| Efficiency | |||||||||||||||||
| Asset turnover | 0.00 | 0.00 | 0.00 | -0.00 | 0.02 | 0.05 | 0.11 | 0.18 | 0.21 | 0.11 | – | – | – | – | 0.97 | 0.77 | – |
| Fixed asset turnover | 0.11 | 0.04 | 0.49 | -0.05 | 3.52 | 7.57 | 4.74 | 10.62 | 27.50 | 15.73 | – | – | – | – | 24.67 | 17.82 | – |
| Receivables turnover | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 4.74 | 3.91 | – |
| Days sales outstanding | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 77.0 | 93.3 | – |
| CapEx to revenue | 26.8% | – | 11.0% | -185.3% | 274.8% | 2.5% | 0.02% | 9.4% | 1.0% | 3.9% | – | – | – | – | 0.29% | 1.8% | – |
| CapEx to OCF | -0.02% | – | -0.06% | -0.20% | -15.5% | -0.59% | -0.01% | -10.4% | -0.56% | -2.0% | -2.7% | -1.1% | -1.2% | – | -0.91% | -2.5% | – |
| CapEx to depreciation | – | – | – | -0.61 | 21.99 | 0.48 | 0.00 | – | – | – | – | – | – | – | 0.15 | 0.37 | – |
| Liquidity | |||||||||||||||||
| Current ratio | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 | 19.16 | 10.04 | 8.70 | 6.11 | 0.82 | 7.90 | 7.46 | 2.11 | 2.64 | 4.25 | 3.83 | – |
| Quick ratio | 18.55 | 13.11 | 17.26 | 11.31 | 11.17 | 19.16 | 10.04 | 8.70 | 6.11 | 0.82 | 7.90 | 7.46 | 2.11 | 2.64 | 4.25 | 3.83 | – |
| Cash ratio | 18.23 | 12.60 | 16.29 | 10.84 | 10.41 | 17.97 | 9.50 | 7.59 | 3.20 | 40.36 | 2.13 | 7.22 | 1.54 | 1.70 | 2.43 | 1.91 | – |
| Working capital | $263.20M | $126.79M | $197.48M | $175.76M | $185.85M | $218.24M | $35.47M | $34.84M | $19.63M | -$983.63K | $15.05M | $16.67M | $7.54M | $12.31M | $15.00M | $17.42M | – |
| Net current asset value | $223.16M | $121.46M | $193.09M | $171.18M | $184.40M | $211.02M | $30.86M | $32.93M | $9.11M | -$1.71M | $14.01M | $15.55M | $4.54M | $8.73M | $12.66M | $8.60M | – |
| Leverage | |||||||||||||||||
| Total debt | $34.29M | – | – | $4.58M | $1.45M | $1.83M | $1.86M | $1.85M | – | – | $0 | $746.15K | $2.82M | $3.78M | – | – | – |
| Net debt | -$239.17M | – | – | -$180.33M | -$188.88M | -$214.13M | -$35.41M | -$32.50M | – | – | -$4.64M | -$17.90M | -$7.66M | -$8.92M | – | – | – |
| Debt / Equity | 0.15 | – | – | 0.02 | 0.01 | 0.01 | 0.04 | 0.04 | – | – | 0.00 | 0.04 | 0.38 | 0.32 | – | – | – |
| Debt ratio | 12.2% | – | – | 2.2% | 0.66% | 0.75% | 3.4% | 3.4% | – | – | 0.00% | 3.4% | 16.5% | 16.6% | – | – | – |
| Assets to equity | 1.24 | 1.13 | 1.09 | 1.12 | 1.10 | 1.09 | 1.19 | 1.13 | 1.60 | 1.19 | 0.46 | 1.20 | 2.34 | 1.95 | 1.44 | 2.23 | – |
| Long-term debt to assets | 12.2% | – | – | 2.2% | 0.66% | 0.75% | 3.4% | 3.4% | – | – | – | – | 4.3% | 7.5% | – | – | – |
| Long-term debt to equity | 0.15 | – | – | 0.02 | 0.01 | 0.01 | 0.04 | 0.04 | – | – | – | – | 0.10 | 0.15 | – | – | – |
| Total debt / Capitalization | 13.2% | – | – | 2.4% | 0.72% | 0.80% | 3.9% | 3.7% | – | – | 0.00% | 3.9% | 27.8% | 24.5% | – | – | – |
| Long-term debt / Capitalization | 13.2% | – | – | 2.4% | 0.72% | 0.80% | 3.9% | 3.7% | – | – | – | – | 9.1% | 12.7% | – | – | – |
| Net debt / EBITDA | – | – | – | 2.05 | 1.96 | 3.94 | 1.68 | – | – | – | – | – | – | 1.50 | – | – | – |
| Total debt / EBITDA | – | – | – | -0.05 | -0.02 | -0.03 | -0.09 | – | – | – | – | – | – | -0.63 | – | – | – |
| Cash flow to debt | -197.0% | – | – | -1,366.2% | -5,380.9% | -1,876.2% | -514.9% | -506.9% | – | – | – | -1,135.7% | -254.0% | -61.4% | – | – | – |
| Goodwill / Assets | – | – | – | – | – | – | 0.00% | 0.00% | – | 48.8% | 113.3% | 10.7% | 13.7% | 10.3% | 10.3% | 8.6% | – |
| Intangibles to total assets | – | 0.00% | 0.00% | 6.0% | 5.7% | 5.2% | 23.6% | 25.3% | 61.4% | 87.8% | 113.3% | 10.7% | 13.7% | 10.3% | 10.3% | 8.6% | – |
| Interest coverage | |||||||||||||||||
| EBIT / Interest expense | -57.76 | -11,463.56 | -2,740.83 | -10,967.50 | -19,382.80 | -5,816.66 | -9,565.48 | -144.18 | -320.99 | -288.10 | -62.34 | -48.44 | -29.56 | -19.30 | -214.86 | -3.97 | – |
| EBITDA / Interest expense | – | – | – | -10,993.13 | -19,272.60 | -5,771.14 | -9,392.88 | – | – | – | – | – | – | -18.36 | -206.41 | -3.80 | – |
| (EBITDA − CapEx) / Interest expense | – | – | – | -11,008.88 | -21,696.00 | -5,792.78 | -9,393.42 | – | – | – | – | – | – | – | -207.72 | -3.86 | – |
| Per share | |||||||||||||||||
| Revenue per share | 0.0004 | 0.0003 | 0.0060 | -0.0014 | 0.11 | 0.22 | 0.38 | 1.14 | 17.65 | 14.04 | – | – | – | – | 140.86 | 127.13 | – |
| EPS (basic) | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 | -1.91 | -1.60 | -15.16 | -118.91 | -49.80 | -14.00 | -47.60 | -64.40 | -28.00 | -22.40 | -302.40 | – |
| EPS (diluted) | -1.00 | -1.34 | -1.66 | -1.81 | -2.35 | -1.91 | -1.60 | -15.16 | -118.91 | -49.80 | -14.00 | -47.60 | -64.40 | -28.00 | -22.40 | -302.40 | – |
| Book value per share | 2.03 | 1.71 | 2.75 | 3.77 | 4.86 | 6.08 | 2.97 | 5.32 | 64.74 | 139.68 | 187.59 | 80.45 | 39.27 | 67.60 | 92.02 | 73.94 | – |
| Tangible book value per share | 2.03 | 1.71 | 2.75 | 3.51 | 4.55 | 5.74 | 2.14 | 3.80 | 1.11 | -6.53 | 89.76 | 70.11 | 26.70 | 54.00 | 78.38 | 59.72 | – |
| Cash per share | 2.47 | 1.82 | 2.80 | 3.76 | 4.64 | 5.81 | 2.43 | 3.78 | 20.22 | 957.64 | 20.17 | 82.07 | 56.11 | 73.55 | 65.23 | 71.37 | – |
| Operating cash flow per share | -0.61 | -1.10 | -1.07 | -1.27 | -1.91 | -0.92 | -0.63 | -1.03 | -33.22 | -27.55 | -13.99 | -37.31 | -38.37 | -13.45 | -45.33 | -90.01 | – |
| Free cash flow per share | -0.61 | – | -1.07 | -1.27 | -2.20 | -0.93 | -0.63 | -1.14 | -33.40 | -28.10 | -14.36 | -37.71 | -38.83 | – | -45.74 | -92.28 | – |
| CapEx per share | 0.0001 | – | 0.0007 | 0.0026 | 0.30 | 0.0055 | 0.0001 | 0.11 | 0.18 | 0.54 | 0.38 | 0.41 | 0.45 | – | 0.41 | 2.27 | – |
| Valuation at period end | |||||||||||||||||
| Market cap | $345.11M | $512.81M | $594.66M | $808.71M | $363.68M | $373.06M | $28.99M | $3.55M | $31.10M | $231.32M | – | – | – | $262.36M | $251.73M | – | – |
| Enterprise value | $148.78M | $373.38M | $458.15M | $611.35M | $165.32M | $168.18M | -$8.46M | -$4.44M | $13.95M | $95.37M | – | – | – | $251.29M | $241.32M | – | – |
| P/S | 8,417x | 25,640x | 1,396x | – | 82.5x | 45.6x | 5.0x | 0.3x | 2.9x | 71.5x | – | – | – | – | 10.4x | – | – |
| P/B | 1.5x | 4.2x | 3.1x | 4.4x | 1.8x | 1.7x | 0.6x | 0.1x | 0.8x | 7.2x | – | – | – | 22.5x | 15.9x | – | – |
| P/TBV | 1.5x | 4.2x | 3.1x | 4.7x | 1.9x | 1.8x | 0.9x | 0.1x | 46.2x | -154x | – | – | – | 28.1x | 18.6x | – | – |
| P/OCF | -5.1x | -6.4x | -7.8x | -12.9x | -4.6x | -10.9x | -3.0x | -0.4x | -1.5x | -36.4x | – | – | – | -113x | -32.2x | – | – |
| EV/Sales | 3,629x | 18,669x | 1,075x | – | 37.5x | 20.5x | -1.5x | -0.4x | 1.3x | 29.5x | – | – | – | – | 9.9x | – | – |
| EV/EBITDA | – | – | – | – | – | – | 0.4x | – | – | – | – | – | – | – | – | – | – |
| EV/EBIT | – | – | – | – | – | – | 0.4x | 0.1x | – | – | – | – | – | – | – | – | – |
| EV/OCF | -2.2x | -4.7x | -6.0x | -9.8x | -2.1x | -4.9x | 0.9x | 0.5x | -0.7x | -15.0x | – | – | – | -108x | -30.9x | – | – |
| EV/FCF | – | – | – | – | – | – | 0.9x | 0.4x | – | – | – | – | – | – | – | – | – |
| Earnings yield | -25.5% | -18.5% | -14.9% | -10.5% | -26.7% | -13.1% | -70.8% | -1,101.9% | -149.3% | -4.8% | – | – | – | -1.9% | -1.5% | – | – |
| FCF yield | -19.6% | – | -12.8% | -7.8% | -24.8% | -9.3% | -33.1% | -291.6% | -65.4% | -2.8% | – | – | – | – | -3.1% | – | – |
| Cost structure | |||||||||||||||||
| R&D to revenue | 162,029.3% | 411,130.0% | 15,445.8% | -103,732.4% | 1,690.3% | 608.1% | 306.2% | 178.7% | 171.4% | 223.1% | – | – | – | – | 87.4% | 99.4% | – |
| Stock-based comp to revenue | 39,209.8% | 71,965.0% | 2,497.7% | -11,913.2% | 125.1% | 31.5% | 21.8% | 7.5% | 13.4% | 29.8% | – | – | – | – | 10.6% | 12.0% | – |
| Per employee | |||||||||||||||||
| Total employees | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 13 | 11 | 2 | 2 | 2 | 2 | 2 | 2 |
| Revenue per employee | $3.15K | $1.54K | $32.77K | – | $339.23K | $629.62K | $446.26K | $794.71K | $826.02K | $248.94K | – | – | – | – | $12.13M | $10.50M | – |
| Operating profit per employee | -$7.27M | -$7.94M | -$7.38M | -$6.75M | -$7.45M | -$4.22M | -$1.65M | -$3.29M | -$4.00M | -$853.20K | -$309.35K | -$5.10M | -$5.42M | -$3.13M | -$5.86M | -$11.78M | – |
| Net income per employee | -$6.78M | -$7.31M | -$6.80M | -$6.52M | -$7.47M | -$3.77M | -$1.58M | -$3.01M | -$3.57M | -$852.83K | -$312.79K | -$4.98M | -$5.86M | -$2.46M | -$1.90M | -$17.42M | – |
| Free cash flow per employee | -$5.20M | – | -$5.84M | -$4.82M | -$6.95M | -$2.65M | -$738.71K | -$797.26K | -$1.56M | -$498.30K | -$300.23K | -$4.28M | -$3.63M | – | -$3.94M | -$7.62M | – |
| Growth | |||||||||||||||||
| Revenue 1Y growth | 105.0% | -95.3% | 726.5% | -101.5% | -46.1% | 41.1% | -43.8% | -3.8% | 231.8% | – | – | – | – | – | 15.6% | – | – |
| Revenue 3Y CAGR | – | -83.4% | -62.7% | – | -24.7% | -8.7% | 21.5% | – | – | – | – | – | – | – | – | – | – |
| Revenue 5Y CAGR | -65.3% | -67.8% | -47.1% | – | 6.4% | – | – | – | – | -33.2% | – | – | – | – | – | – | – |
| Revenue 10Y CAGR | – | – | – | – | -15.7% | -9.0% | – | – | – | – | – | – | – | – | – | – | – |
| EBIT 1Y growth | 8.4% | -7.6% | -9.3% | 9.5% | -76.9% | -155.3% | 49.9% | 17.7% | -369.2% | -226.0% | 66.6% | 6.0% | -73.0% | 46.6% | 50.2% | – | – |
| EBITDA 1Y growth | – | – | – | 8.7% | -77.2% | -158.0% | – | – | – | – | – | – | – | 47.1% | 50.0% | – | – |
| Net income 1Y growth | 7.3% | -7.5% | -4.4% | 12.7% | -98.0% | -139.0% | 47.6% | 15.6% | -318.7% | -222.2% | 65.4% | 15.0% | -138.2% | -29.6% | 89.1% | – | – |
| Diluted EPS 1Y growth | 25.4% | 19.3% | 8.3% | 23.0% | -23.0% | -19.4% | 89.4% | 87.3% | -138.8% | -255.7% | 70.6% | 26.1% | -130.0% | -25.0% | 92.6% | – | – |
| Operating cash flow 1Y growth | 15.4% | -5.3% | -21.1% | 20.0% | -128.1% | -257.3% | -2.3% | 53.6% | -218.2% | -97.5% | 62.0% | -18.2% | -208.6% | 70.3% | 47.5% | – | – |
| Free cash flow 1Y growth | – | – | -21.0% | 30.6% | -161.8% | -259.4% | 7.3% | 49.0% | -213.8% | -96.2% | 61.4% | -18.1% | – | – | 48.3% | – | – |
| CapEx 1Y growth | – | – | -62.7% | -99.0% | 5,841.0% | 16,522.4% | -99.9% | 767.5% | -10.0% | 44.4% | -6.2% | 9.1% | – | – | -80.9% | – | – |
| CapEx 3Y CAGR | -55.6% | – | -38.7% | 368.3% | 131.6% | 22.0% | -78.6% | 124.2% | 6.8% | 13.9% | – | 8.9% | -39.1% | – | – | – | – |
| CapEx 5Y CAGR | -44.2% | – | -45.5% | 2.3% | 149.6% | 18.7% | -57.9% | 63.1% | – | 11.8% | -25.4% | – | – | – | – | – | – |
| CapEx 10Y CAGR | -18.6% | – | -5.7% | – | 67.1% | -5.9% | – | – | – | – | – | – | – | – | – | – | – |
| Total assets 1Y growth | 100.9% | -33.9% | 1.8% | -5.5% | -10.7% | 353.4% | -1.3% | -13.1% | 64.1% | 93.3% | -9.6% | 28.2% | -24.6% | -0.27% | -16.2% | – | – |
| Total assets 3Y CAGR | 10.6% | -14.0% | -4.9% | 56.4% | 58.7% | 57.3% | 12.1% | 40.2% | 42.1% | 30.9% | -4.4% | -1.2% | -14.3% | – | – | – | – |
| Total assets 5Y CAGR | 2.7% | 20.8% | 30.9% | 26.8% | 41.6% | 65.3% | 19.7% | 26.1% | 22.6% | 11.0% | -6.1% | – | – | – | – | – | – |
| Total assets 10Y CAGR | 30.3% | 20.3% | 28.5% | 24.7% | 25.4% | 24.6% | – | – | – | – | – | – | – | – | – | – | – |
| Total equity 1Y growth | 82.1% | -36.4% | 4.8% | -7.0% | -11.8% | 396.2% | -5.8% | 22.6% | 22.3% | -25.3% | 136.0% | 149.1% | -37.2% | -26.4% | 29.8% | 287.3% | – |
| Total equity 3Y CAGR | 6.7% | -14.7% | -4.9% | 59.7% | 60.3% | 79.0% | 12.2% | 3.9% | 29.2% | 63.7% | 54.6% | 4.9% | -15.6% | 54.7% | – | – | – |
| Total equity 5Y CAGR | -0.09% | 22.1% | 32.1% | 36.3% | 44.0% | 39.3% | 20.0% | 45.8% | 27.5% | 15.2% | 28.7% | 42.1% | – | – | – | – | – |
| Total equity 10Y CAGR | 18.0% | 21.1% | 38.8% | 31.8% | 28.8% | 33.9% | 30.6% | – | – | – | – | – | – | – | – | – | – |
Every figure here is calculated from standardized financial statements — hover a row name for the formula — not reported by the company. Valuation multiples use the closing price at the end of that period, not today's price.